Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.
作者信息
Shakeri Ahmad, Gomes Tara, Suda Katie, Tadrous Mina
机构信息
Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Unity Health Toronto, Toronto, ON, Canada.
出版信息
Basic Clin Pharmacol Toxicol. 2021 May;128(5):649-651. doi: 10.1111/bcpt.13568. Epub 2021 Feb 19.
Abstract
摘要
相似文献
1
Choppy waters: The importance of accounting for shifting drug utilization during the COVID-19 pandemic in future observational drug-related studies.波涛汹涌的水域：在未来的药物相关观察性研究中考虑新冠疫情期间药物使用变化的重要性。
Basic Clin Pharmacol Toxicol. 2021 May;128(5):649-651. doi: 10.1111/bcpt.13568. Epub 2021 Feb 19.
2
Risks of potential drug-drug interactions in COVID-19 patients treated with corticosteroids: a single-center experience.接受皮质类固醇治疗的COVID-19患者潜在药物相互作用的风险：单中心经验
J Endocrinol Invest. 2021 Dec;44(12):2849-2851. doi: 10.1007/s40618-021-01604-6. Epub 2021 May 30.
3
Medication shortages during the COVID-19 pandemic: Saving more than COVID lives.新冠疫情期间的药品短缺：拯救的不止是新冠患者的生命。
Am J Emerg Med. 2021 Jul;45:557-559. doi: 10.1016/j.ajem.2020.07.044. Epub 2020 Jul 24.
4
[Multi-medication and unsuitable prescription of drugs for elderly patients: are we doing what we can?].[老年患者的多重用药及不适当用药处方：我们是否已竭尽全力？]
Aten Primaria. 2006 Nov 30;38(9):480-2. doi: 10.1157/13095050.
5
Administration of end-of-life drugs by family caregivers during covid-19 pandemic.在新冠疫情期间家庭护理人员给予临终药物的情况。
BMJ. 2020 Apr 24;369:m1615. doi: 10.1136/bmj.m1615.
6
Personal medication preparedness among veteran and nonveteran men and women in the California population.加利福尼亚州人群中退伍军人和非退伍军人男性和女性的个人用药准备情况。
Prehosp Disaster Med. 2013 Aug;28(4):359-66. doi: 10.1017/S1049023X13003506. Epub 2013 Apr 26.
7
USA stockpiling of remdesivir: How should the world respond?美国囤积瑞德西韦：世界应如何应对？
J Comp Eff Res. 2020 Dec;9(18):1243-1246. doi: 10.2217/cer-2020-0174. Epub 2020 Dec 4.
8
[Future drug utilization].[未来药物利用情况]
Ugeskr Laeger. 1995 Oct 2;157(40):5562.
9
Are there positive lessons for Italy's NHS resulting from the Covid-19 pandemic?新冠疫情给意大利国民医疗服务体系带来了哪些积极的经验教训？
Med Leg J. 2020 Jul;88(2):84-86. doi: 10.1177/0025817220923698. Epub 2020 May 18.
10
Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.续方依从性以及自我报告的药物不良反应和亚治疗效应：一项基于人群的研究。
Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1317-25. doi: 10.1002/pds.3528. Epub 2013 Oct 11.
引用本文的文献
1
Trends in medication use during the COVID-19 pandemic in Quebec, Canada.加拿大魁北克省新冠疫情期间的用药趋势。
Sci Rep. 2025 Apr 27;15(1):14744. doi: 10.1038/s41598-025-98592-x.
2
Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study.加拿大曼尼托巴省 COVID-19 大流行前后的药物利用模式：一项基于人群的研究。
PLoS One. 2022 Nov 28;17(11):e0278072. doi: 10.1371/journal.pone.0278072. eCollection 2022.
3
COVID-19 and the prevalence of drug shortages in Canada: a cross-sectional time-series analysis from April 2017 to April 2022.COVID-19 与加拿大药物短缺的流行：2017 年 4 月至 2022 年 4 月的横断面时间序列分析。
CMAJ. 2022 Jun 13;194(23):E801-E806. doi: 10.1503/cmaj.212070.
4
Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries.COVID-19 大流行期间孕妇和哺乳期妇女自我报告的用药情况：五个欧洲国家的横断面研究。
Int J Environ Res Public Health. 2022 Jan 26;19(3):1389. doi: 10.3390/ijerph19031389.
本文引用的文献
1
Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.羟氯喹对 COVID-19 住院患者 14 天临床状态的影响：一项随机临床试验。
JAMA. 2020 Dec 1;324(21):2165-2176. doi: 10.1001/jama.2020.22240.
2
Hydroxychloroquine Sulfate Prescribing Trends and Pharmacist-Led Outbreak Preparedness in Long-Term Care Pharmacy during Coronavirus Disease 2019.2019年冠状病毒病期间长期护理药房硫酸羟氯喹的处方趋势及药剂师主导的疫情防范措施
J Am Med Dir Assoc. 2020 Jul;21(7):1000-1001. doi: 10.1016/j.jamda.2020.06.012. Epub 2020 Jun 10.
3
The Impact of the COVID-19 "Infodemic" on Drug-Utilization Behaviors: Implications for Pharmacovigilance.COVID-19“信息疫情”对药物利用行为的影响：对药物警戒的启示。
Drug Saf. 2020 Aug;43(8):699-709. doi: 10.1007/s40264-020-00965-w.
4
Hydroxychloroquine for the Prevention of Covid-19 - Searching for Evidence.羟氯喹预防新型冠状病毒肺炎——寻找证据
N Engl J Med. 2020 Aug 6;383(6):585-586. doi: 10.1056/NEJMe2020388. Epub 2020 Jun 3.
5
Medication Shortages During the COVID-19 Crisis: What We Must Do.新冠疫情危机期间的药品短缺：我们必须采取的措施。
Mayo Clin Proc. 2020 Jun;95(6):1112-1115. doi: 10.1016/j.mayocp.2020.04.001. Epub 2020 Apr 3.
6
COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: What Is the Evidence?新型冠状病毒肺炎与血管紧张素转换酶抑制剂及血管紧张素受体阻滞剂：证据是什么？
JAMA. 2020 May 12;323(18):1769-1770. doi: 10.1001/jama.2020.4812.
7
Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study.加拿大安大略省与启动阿片类药物治疗疼痛管理相关的临床指征：一项基于人群的队列研究。
Pain. 2018 Aug;159(8):1562-1568. doi: 10.1097/j.pain.0000000000001242.
Zotero 插件